Lactobacillus rhamnosus GG ATCC 53103 (LGG) as an Immune Adjuvant for Influenza Vaccination in the Elderly

Gloria Solano-Aguilar,Aleksey Molokin,Christine Botelho,Anne-Maria Fiorino,Bryan T. Vinyard,Joseph F. Urban,Miriam Haverkamp,Patricia L. Hibberd

Lactobacillus rhamnosus GG ATCC 53103 (LGG) as an Immune Adjuvant for Influenza Vaccination in the Elderly

2015

Gloria Solano-Aguilar
Aleksey Molokin
Christine Botelho
Anne-Maria Fiorino
Bryan T. Vinyard
Joseph F. Urban
Miriam Haverkamp
Patricia L. Hibberd

Annual vaccination against seasonal influenza in the U.S. is recommended for all persons aged 蠅 6 months. A moderate effectiveness for influenza vaccines of approximately 60% has been estimated. Li...

Keywords:

Lactobacillus rhamnosus
Endocrinology
Diabetes mellitus
Vaccination
Internal medicine
Immune adjuvant
Immunology
Biology
seasonal influenza

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations